🇺🇸 FDA
Patent

US 11203583

Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting

granted A61KA61K47/50A61K47/545

Quick answer

US patent 11203583 (Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K47/50, A61K47/545, A61K49/0032, A61K49/0052